Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer
Saved in:
| Published in: | Rare Cancers and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868553898746183680 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Rare Cancers and Therapy |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:90820 |
| institution | FRELIP |
| journal_source_facet | Rare Cancers and Therapy |
| last_indexed | 2026-06-20T21:44:11.953Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer |
| title_alt | Más allá de la paradoja BCG: Racional biológico y evidencia clínica para combinar BCG intravesical con inhibidores de puntos de control inmunitarios en cáncer de vejiga no músculo-invasivo de alto riesgo Au-delà du paradoxe du BCG : justification biologique et preuves cliniques pour la combinaison du BCG intravésical avec des inhibiteurs de points de contrôle immunitaires dans le cancer de la vessie non invasif musculaire à haut risque Além do Paradoxo BCG: Racional Biológico e Evidência Clínica para Combinar BCG Intravesical com Inibidores de Checkpoint Imune no Câncer de Bexiga Não Músculo-Invasivo de Alto Risco |
| title_auth | Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer |
| title_es_txt | Más allá de la paradoja BCG: Racional biológico y evidencia clínica para combinar BCG intravesical con inhibidores de puntos de control inmunitarios en cáncer de vejiga no músculo-invasivo de alto riesgo |
| title_fr_txt | Au-delà du paradoxe du BCG : justification biologique et preuves cliniques pour la combinaison du BCG intravésical avec des inhibiteurs de points de contrôle immunitaires dans le cancer de la vessie non invasif musculaire à haut risque |
| title_full | Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer |
| title_fullStr | Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer |
| title_full_unstemmed | Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer |
| title_pt_txt | Além do Paradoxo BCG: Racional Biológico e Evidência Clínica para Combinar BCG Intravesical com Inibidores de Checkpoint Imune no Câncer de Bexiga Não Músculo-Invasivo de Alto Risco |
| title_short | Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer |
| title_sort | beyond the bcg paradox: biological rationale and clinical evidence for combining intravesical bcg with immune checkpoint inhibitors in high-risk non-muscle-invasive bladder cancer |
| topic | Oncology General Oncology |
| url | https://link.springer.com/article/10.1007/s40487-026-00445-8 |